trending Market Intelligence /marketintelligence/en/news-insights/trending/8td22lzWceBDmq_axxNe4Q2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

AngioDynamics sues C.R. Bard for allegedly violating federal antitrust laws

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


AngioDynamics sues C.R. Bard for allegedly violating federal antitrust laws

AngioDynamics Inc. filed a lawsuit against C. R. Bard Inc., alleging that its competitor violated federal antitrust laws by tying the sales of its tip location devices with its own peripherally inserted central catheters, or PICCs.

"By doing so, customers who want to buy Bard's tip location systems must also buy Bard's line of PICCs, preventing hospitals and other medical providers from purchasing AngioDynamics' superior BioFlo PICCs," the company claimed in its lawsuit filed with the U.S. District Court for the Northern District of New York.

Tip locators detect the ideal spot for catheter insertion to administer drugs directly into a patient's bloodstream.

Angiodynamics claims that Bard's practice of preloading its catheter tip placement devices onto its own catheter harms competition and limits access to patients.

The company is seeking to end Bard's "violation of the antitrust laws" and recover damages for its losses.

AngioDynamics is represented by law firm Boies Schiller Flexner LLP.